Observational studyLipids in health and disease2026
Gestational lipid profile partially mediates adverse obstetric outcomes associated with polycystic ovary syndrome: a multicentre cohort study in China.
Observational study in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundPolycystic ovary syndrome (PCOS) is associated with dyslipidaemia and adverse obstetric outcomes. Even among nonobese women, triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) levels differ between those with and without PCOS. This study aimed to elucidate the role of gestational lipid profiles in the association of PCOS with obstetric outcomes.
methodsThis multicentre retrospective cohort study enrolled 2,515 pregnant women from 2016 to 2021 at 3 hospitals (1 provincial and 2 municipal) to assess the associations between maternal PCOS (exposure), obstetric outcomes (cesarean delivery, gestational complications, foetal ultrasonographic biometric measurements and neonatal unit admission), and lipid profile markers (mediators) using multivariate linear and logistic regression models and mediation analyses.
resultsPregnant women with PCOS were more likely to have a cesarean delivery (OR = 1.28, 95% CI 1.08, 1.52) than those without PCOS were. The levels of maternal lipid profile markers were associated with cesarean delivery [triglyceride (log TG): OR = 1.62, 95% CI 1.29, 2.03; high-density lipoprotein-cholesterol (HDL-C): OR = 0.67, 95% CI 0.53, 0.85]. These associations were independent of maternal age, educational attainment, the rate of total gestational weight gain (GWG), gravidity, parity, and neonatal sex. In terms of the association between maternal PCOS and cesarean delivery, the mediation effect of TG was 0.010 (95% CI 0.005, 0.016), and that of HDL-C was 0.007 (95% CI 0.002, 0.013). With respect to the secondary outcomes, both TG and HDL-C partially mediated the link between maternal PCOS and pregnancy hypertensive disorders and biparietal diameter in late pregnancy, whereas only TG partially mediated the effect of maternal PCOS on gestational diabetes mellitus and preterm delivery. HDL-C partially mediated the effect of maternal PCOS on admission to neonatal units.
conclusionsGestational lipid profile markers partially mediated the link between maternal PCOS and adverse obstetric outcomes, including cesarean delivery, gestational complications, foetal ultrasonographic biometric measurements and neonatal unit admission, across different conception modes, independent of maternal age, educational attainment, the rate of total GWG, gravidity, parity and neonatal sex.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.